HFA Premium Access

STEP HFpEF trial design and baseline characteristics

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Congress Presentation

About the speaker

Doctor Mikhail Kosiborod

St. Luke's Mid America Heart Institute, Kansas City (United States of America)
55 presentations
10 followers

4 more presentations in this session

PARAGLIDEHF: Sacubitril/Valsartan versus valsartan on changes in NTproBNP, safety, and tolerability in patients with EF>40% stabilized after a WHF Event

Speaker: Doctor R. Mentz (Durham, US)

Thumbnail

A pre-specified, participant-level pooled analysis of PARAGON-HF and PARAGLIDE-HF

Speaker: Doctor M. Vaduganathan (Boston, US)

Thumbnail

DAPA-RESIST clinical trial - Dapagliflozin versus metolazone in heart failure with diuretic resistance

Speaker: Doctor R. Campbell (Glasgow, GB)

Thumbnail

Verinurad plus allopurinol for heart failure with preserved ejection fraction: results from the AMETHYST randomized controlled trial

Speaker: Professor A. Voors (Groningen, NL)

Thumbnail

Access the full session

Late breaking clinical trials: medical therapy

Speakers: Doctor M. Kosiborod, Doctor R. Mentz, Doctor M. Vaduganathan, Doctor R. Campbell, Professor A. Voors
Thumbnail

About the event

Image

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations